Mefenamic Acid, 250mg capsules, packaged in 30-count bottles, Rx Only, Distributed by: Prasco Laboratories Mason, OH 45040 USA, Manufactured by: Halo Pharmaceutical Inc. Whippany, NJ 07981, NDC 66993-070-30
Published July 26, 2017 · Recall initiated: May 24, 2017
Summary
FDA records drug Class III recall D-0981-2017, published July 26, 2017 and initiated May 24, 2017. Recalling firm: Shionogi Inc.; Status: Terminated; Reported quantity: 6304 bottles; Lot: Lot #: 5H66200103G, Exp. June 2018. Class III means the product is not likely to cause adverse health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Dissolution Specifications: Low dissolution results were obtained during stability testing
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Shionogi Inc.
- Distributor
- Nationwide
- Lot
- Lot #: 5H66200103G, Exp. June 2018.
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAMefenamic Acid Capsules, USP, 250 mg, 30-count bottle, Rx only, Distributed by Prasco Laboratories, Mason, OHJanuary 24, 2018
- FDAPONSTEL (Mefanamic Acid) USP, 250 mg capsules, 30-count bottles, Rx Only, Manufactured for: Shionogi Inc.July 26, 2017
- FDAArgatroban Injection, 250 mg/2.5 mL (100 mg/mL), 5 mL Single-use vial, Rx Only, Sterile, Manufactured by:July 26, 2017
- FDABuprenorphine and Naloxone Sublingual Tablets, 2 mg/0.5 mg 30 tablets per bottle, Rx only, Distributed by:July 26, 2017
- FDAATAR Disposable Extension Cable, sold under brand names: ATAR Disposable Series, ATAR 53912 Disposable Series,July 19, 2017
- FDANisoldipine Extended Release Tablets, 17mg, 100 count bottle, Rx only, Manufactured for: Prasco LaboratoriesJuly 4, 2012
Questions about this recall
Was Mefenamic Acid, 250mg capsules, packaged in 30-count bottles, Rx Only, Distributed by: Prasco Laboratories Mason, OH 45040 USA, Manufactured by: Halo Pharmaceutical Inc. Whippany, NJ 07981, NDC 66993-070-30 recalled?
Yes. FDA published recall D-0981-2017 on July 26, 2017. Reported hazard: Failed Dissolution Specifications: Low dissolution results were obtained during stability testing
What should I do if I have this product?
Voluntary: Firm initiated · Letter